Société Lonza Group AG Börse Stuttgart
Actions
LO3A
US54338V1017
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
50 EUR | +1,21 % |
|
+1,63 % | +35,87 % |
Métier
- produits bio-pharmaceutiques (55,4%) : synthèses exclusives, produits de fermentation microbiologique, cultures de cellules mammifères, etc. ;
- capsules et solutions de dosage de produits biopharmaceutiques, de médicaments et de produits de nutrition (17,3%). Par ailleurs, le groupe propose des ingrédients nutritionnels ;
- substances médicamenteuses à petites molécules (13,4%) ;
- technologies et plateformes permettant de mettre en oeuvre les processus de fabrication et la production de thérapies cellulaires et géniques (10,4%) ;
- autres (3,5%).
La répartition géographique du CA est la suivante : Suisse (17,4%), Europe (31,7%), Etats-Unis (31,8%), Amériques (3,2%), Japon (8,1%) Asie (7,5%) et autres (0,3%).
Ventes par activité
CHF en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Biologics
55,4
%
| 3 274 | 52,6 % | 3 719 | 55,4 % | +13,59 % |
Capsules & Health Ingredients
17,3
%
| 1 266 | 20,3 % | 1 161 | 17,3 % | -8,29 % |
Small Molecules
13,4
%
| 819 | 13,2 % | 901 | 13,4 % | +10,01 % |
Cell & Gene
10,4
%
| 693 | 11,1 % | 696 | 10,4 % | +0,43 % |
Corporate/Eliminations
3,6
%
| 171 | 2,7 % | 240 | 3,6 % | +40,35 % |
Ventes par région
CHF en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
31,8
%
| 2 415 | 38,8 % | 2 136 | 31,8 % | -11,55 % |
Switzerland
17,4
%
| 996 | 16,0 % | 1 168 | 17,4 % | +17,27 % |
Japan
8,1
%
| 227 | 3,6 % | 544 | 8,1 % | +139,65 % |
Ireland
5,5
%
| 343 | 5,5 % | 368 | 5,5 % | +7,29 % |
Belgium
5,1
%
| 302 | 4,9 % | 341 | 5,1 % | +12,91 % |
Denmark
4,8
%
| 158 | 2,5 % | 322 | 4,8 % | +103,80 % |
Germany
4,5
%
| 224 | 3,6 % | 302 | 4,5 % | +34,82 % |
Rest of Europe
2,9
%
| 207 | 3,3 % | 195 | 2,9 % | -5,80 % |
China
2,6
%
| 161 | 2,6 % | 172 | 2,6 % | +6,83 % |
United Kingdom
2,5
%
| 139 | 2,2 % | 171 | 2,5 % | +23,02 % |
Singapore
2,0
%
| 113 | 1,8 % | 137 | 2,0 % | +21,24 % |
Sweden
1,8
%
| 143 | 2,3 % | 123 | 1,8 % | -13,99 % |
France
1,7
%
| 116 | 1,9 % | 111 | 1,7 % | -4,31 % |
South Korea
1,4
%
| 141 | 2,3 % | 97 | 1,4 % | -31,21 % |
Canada
1,3
%
| 63 | 1,0 % | 90 | 1,3 % | +42,86 % |
Netherlands
1,3
%
| 132 | 2,1 % | 88 | 1,3 % | -33,33 % |
Brazil
1,1
%
| 49 | 0,8 % | 71 | 1,1 % | +44,90 % |
Italy
0,8
%
| 41 | 0,7 % | 52 | 0,8 % | +26,83 % |
India
0,6
%
| 42 | 0,7 % | 42 | 0,6 % | 0,00 % |
Spain
0,6
%
| 41 | 0,7 % | 40 | 0,6 % | -2,44 % |
Mexico
0,5
%
| 34 | 0,5 % | 33 | 0,5 % | -2,94 % |
Rest of Asia
0,4
%
| 36 | 0,6 % | 29 | 0,4 % | -19,44 % |
Rest of Latin America
0,4
%
| 38 | 0,6 % | 26 | 0,4 % | -31,58 % |
Australia & New Zealand
0,2
%
| 21 | 0,3 % | 16 | 0,2 % | -23,81 % |
Thailand
0,2
%
| 15 | 0,2 % | 15 | 0,2 % | 0,00 % |
Indonesia
0,2
%
| 16 | 0,3 % | 14 | 0,2 % | -12,50 % |
Czech Republic
0,2
%
| 7 | 0,1 % | 11 | 0,2 % | +57,14 % |
Other Countries
0,0
%
| 2 | 0,0 % | 2 | 0,0 % | 0,00 % |
Rest of North and Central America
0,0
%
| 1 | 0,0 % | 1 | 0,0 % | 0,00 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Albert Baehny
CEO | Chief Executive Officer | 72 | 25/04/17 |
Philippe Deecke
DFI | Director of Finance/CFO | 52 | 01/12/21 |
Maria Nunez
COO | Chief Operating Officer | 55 | 01/08/22 |
Lyle Wheeler
IRC | Investor Relations Contact | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 63 | 16/04/14 |
Director/Board Member | 66 | 16/04/14 | |
Marion Helmes
BRD | Director/Board Member | 58 | 05/05/22 |
Albert Baehny
CEO | Chief Executive Officer | 72 | 25/04/17 |
Christoph Mäder
BRD | Director/Board Member | 64 | 26/04/16 |
Roger Nitsch
BRD | Director/Board Member | 63 | 01/05/22 |
Director/Board Member | 64 | 04/05/18 | |
Director/Board Member | 52 | 04/05/18 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 72 226 184 | 69 832 097 ( 96,69 %) | 2 352 163 ( 3,257 %) | 96,69 % |
Participations
Nom | Actions | % | Valorisation |
---|---|---|---|
LONZA GROUP AG 3,16% | 2 352 163 | 3,16% | 1 268 183 853 $ |
Coordonnées société
![Adresse Lonza Group AG(LO3A)](https://cdn.zonebourse.com/static/address/107428138.png)
Sociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Arch Protection Chemicals Pvt Ltd.
![]() Arch Protection Chemicals Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Lonza Group AG, Arch Protection Chemicals Pvt Ltd. is an Indian company that provides business services. The company is based in Mumbai, India. |
Miscellaneous Commercial Services
|
Capsugel Germany GmbH
| |
Lonza Swiss Finanz AG
![]() Lonza Swiss Finanz AG Finance/Rental/LeasingFinance Lonza Swiss Finanz AG engages in the provision of financing services within the companies of Lonza Group AG. It also invests in domestic and foreign industrial and commercial firms. The company was founded on December 23, 1974 and is headquartered in Basel, Switzerland. |
Finance/Rental/Leasing
|
Arxada AG
![]() Arxada AG Chemicals: Major DiversifiedProcess Industries Arxada AG is a Swiss specialty chemicals company that offers consumer microbial control, industrial microbial control, and specialty product solutions. The company is based in Basel, CH, and has subsidiaries in the Netherlands, United States, and Thailand. The company provides a wide range of differentiated products for various end markets, including hygiene, home and personal care, wood protection, crop protection, and food, beverage, and water. Arxada has leading regulatory capabilities, IP expertise, and an established track record in the industry. C. Marc Doyle has been the CEO of the company since 2021. |
Chemicals: Major Diversified
|
Capsugel FinanceCo SARL
| |
Xcelience Clinical Services Ltd.
![]() Xcelience Clinical Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of MW Encap (Holdings) Ltd., Xcelience Clinical Services Ltd. provides packaging services. The company is based in London, UK. |
Miscellaneous Commercial Services
|
Capsugel Plöermel SASU
![]() Capsugel Plöermel SASU BiotechnologyHealth Technology Capsugel Plöermel SASU designs and manufactures biopharmaceuticals. The company is headquartered in Ploermel, France. |
Biotechnology
|
Capsugel Belgium SA
![]() Capsugel Belgium SA Pharmaceuticals: MajorHealth Technology Capsugel Belgium NV provides dosage forms and solutions. The firm also sells equipment for filling empty and liquid capsules and equipment for sealing liquid capsules. The company was founded on October 1, 1961 and is headquartered in Bornem, Belgium. |
Pharmaceuticals: Major
|
Capsugel Italy SRL
![]() Capsugel Italy SRL Miscellaneous Commercial ServicesCommercial Services Part of Chester Investor Holdings SRL, Capsugel Italy SRL provides management consulting services. The company is based in Milan, Italy. |
Miscellaneous Commercial Services
|
Secteur
Ventes par activité
Ventes par région
![Consensus](/images/consensus_flch.gif)
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+19,41 % | 45,51 Md | |
-8,62 % | 38,52 Md | |
+26,95 % | 30,74 Md | |
-13,50 % | 26,03 Md | |
+10,74 % | 25,92 Md | |
+44,87 % | 14,13 Md | |
+34,36 % | 12,73 Md | |
-7,14 % | 11,29 Md | |
-12,61 % | 10,64 Md |
- Bourse
- Actions
- Action LONN
- Action LO3A
- Société Lonza Group AG